No Matches Found

The March 2026 quarterly earnings season has revealed a steady improvement in corporate profitability, with 54.0% of companies reporting positive results, marking a notable rise from 41.0% in June 2025. Mid-cap stocks have emerged as the strongest performers, outpacing large and small caps in terms of positive earnings surprises and profit growth, signalling a shift in market dynamics as investors weigh sectoral trends and company-specific fundamentals. Read Full Story
{{ mcg.name }}
{{ mcg.value }}
{{ mcg.chg }} ({{ mcg.per}})
The large-cap segment, represented by the BSE 100 index, has experienced a notable decline over recent sessions, reflecting a cautious market mood. While select heavyweight stocks have managed modest gains, the broader index has been weighed down by a significant number of decliners, highlighting a divergence between defensive and cyclical sectors. Read Full Story
Stock Market News | May 29 2026 04:00 PM IST
The BSE Midcap 150 index declined by 1.25% on 29 May 2026, reflecting a cautious mood among investors as sectoral disparities and stock-specific movements shaped the trading session. While some mid-cap stocks delivered notable gains, the broader segment faced pressure with a significant number of declines, underscoring the uneven performance within this vital market segment. Read Full Story
Stock Market News | May 29 2026 04:00 PM IST
The small-cap segment, represented by the BSE SMALLCAP 250 index, experienced a modest decline of 0.61% on 29 May 2026, reflecting a cautious market mood amid uneven sectoral performances and mixed breadth indicators. While select stocks delivered robust returns, the overall segment grappled with more decliners than advancers, signalling a nuanced outlook for investors. Read Full Story
Stock Market News | May 29 2026 04:00 PM IST
Indian Indices
{{key}}
SENSEX
74,775.74
-1,092.06

-1.44%

NIFTY
23,547.75
-359.40

-1.50%

BSE100
25,059.09
-371.62

-1.46%

BSE200
11,035.46
-156.05

-1.39%

BSE500
35,417.64
-481.52

-1.34%

Indian Indices
{{key}}
{{miiv.sensex}}
{{miiv.cmp}}
{{miiv.chg}}

{{miiv.chgp}}

Sectoral Indices
{{key}}
BANKNIFTY
54,239.20
-614.65

-1.12%

NIFTYIT
29,080.15
173.45

0.60%

NIFTYFINANCE
25,354.00
-398.20

-1.55%

NIFTYPHARMA
24,345.80
-370.20

-1.50%

NIFTYFMCG
49,383.35
-758.55

-1.51%

NIFTYMNC
32,455.90
-362.45

-1.10%

NIFTYAUTO
26,338.45
-525.75

-1.96%

NIFTYMETAL
13,440.95
-277.35

-2.02%

NIFTYCPSE
7,008.85
-172.95

-2.41%

Sectoral Indices
{{key}}
{{msiv.sensex}}
{{msiv.cmp}}
{{msiv.chg}}

{{msiv.chgp}}

Top Gainers - NIFTY500
Company

Latest Price

Change

Change (%)

Day's High

Day's Low

626.50

(15.39%)

4,763.50

4,048.85

Wockhardt

2030.70

259.05

(14.62%)

2,096.45

1,871.85

Tega Inds.

1764.00

164.30

(10.27%)

1,829.20

1,521.15

Top Losers - NIFTY500
Company

Latest Price

Change

Change (%)

Day's High

Day's Low

Natco Pharma

1016.75

-158.85

(-13.51%)

1,200.00

1,001.05

-60.40

(-9.19%)

669.95

587.35

-204.40

(-6.47%)

3,177.95

2,908.55

{{ar.card_header}}

{{ ar.title }}
{{ ar.positive }}%
{{ ar.positive_cnt }}
{{ ar.flat }}%
{{ ar.flat_cnt }}
{{ ar.negative }}%
{{ ar.negative_cnt }}
{{arl.sname}}

{{arl.date}}

{{arl.sector}}

{{arl.cap}}

{{arl.performance}}
{{arl.score}}
Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Most Read

Rudra Ecovation Q4 FY26: Deep Losses Persist as Operational Struggles Continue

Rudra Ecovation Ltd., a micro-cap textile manufacturer operating in the garments and apparels sector, reported a net loss of ₹1.39 crores for Q4 FY26, marking the seventh consecutive quarter of losses. The company's shares, currently trading at ₹19.11 with a market capitalisation of ₹222.00 crores, have declined 1.29% following the results announcement, extending a brutal one-year decline of 61.34% that has significantly underperformed both the Sensex and the broader garments sector.

2 hours ago
Share Via
Rudra Ecovation Q4 FY26: Deep Losses Persist as Operational Struggles Continue

Jayant Agro Organics Q4 FY26: Stellar Quarter Masks Underlying Growth Concerns

Jayant Agro Organics Ltd., a Mumbai-based speciality chemicals manufacturer focused on castor oil derivatives, delivered a standout performance in Q4 FY26 with consolidated net profit surging 155.12% quarter-on-quarter to ₹17.68 crores, marking the company's strongest quarterly showing in recent history. However, this impressive sequential recovery comes against a backdrop of persistent structural challenges, with the micro-cap stock languishing 23.38% below its 52-week high of ₹290.00 despite trading at ₹222.20 as of May 29, 2026, reflecting investor scepticism about the sustainability of this turnaround.

2 hours ago
Share Via
Jayant Agro Organics Q4 FY26: Stellar Quarter Masks Underlying Growth Concerns

Welcure Drugs Q4 FY26: Massive Loss Wipes Out Year's Gains

Welcure Drugs & Pharmaceuticals Ltd. reported a catastrophic fourth quarter for FY26, posting a net loss of ₹49.86 crores compared to a profit of ₹2.54 crores in the same quarter last year. The micro-cap pharmaceutical company's shares, trading at ₹0.29 on the NSE, have plunged 73.15% over the past year, reflecting investor alarm over the dramatic deterioration in operational performance.

2 hours ago
Share Via
Welcure Drugs Q4 FY26: Massive Loss Wipes Out Year's Gains

Emergent Industrial Solutions Q4 FY26: Profit Surge Masks Underlying Fragility

Emergent Industrial Solutions Limited reported a dramatic swing to profitability in Q4 FY26, posting net profit of ₹1.33 crores compared to a loss of ₹1.08 crores in the year-ago quarter. However, the micro-cap non-ferrous metals company's shares have declined sharply, trading at ₹419.50 as of May 29, down 57.63% from their 52-week high of ₹990.15, as investors remain sceptical about the sustainability of this turnaround.

2 hours ago
Share Via
Emergent Industrial Solutions Q4 FY26: Profit Surge Masks Underlying Fragility

iStreet Network Q4 FY26: Explosive Revenue Growth Masks Margin Erosion and Valuation Concerns

iStreet Network Ltd., a micro-cap player in India's e-retail and e-commerce sector, reported a dramatic revenue surge in Q4 FY26, though the quarter's performance revealed troubling margin compression and raised serious questions about the sustainability of its current ₹321.00 crore valuation. Net profit for the quarter ended March 2026 stood at ₹0.39 crores, representing a sharp 67.50% decline quarter-on-quarter from ₹1.20 crores in Q3 FY26, even as the company posted its highest-ever quarterly revenue of ₹41.49 crores.

2 hours ago
Share Via
iStreet Network Q4 FY26: Explosive Revenue Growth Masks Margin Erosion and Valuation Concerns

Foods & Inns Q4 FY26: Strong Quarter Masks Underlying Weakness

Foods & Inns Ltd., a micro-cap processed foods manufacturer with a market capitalisation of ₹409.00 crores, reported a dramatic turnaround in Q4 FY26 with consolidated net profit surging to ₹19.49 crores, representing a staggering quarter-on-quarter growth of 4,432.56% from the meagre ₹0.43 crores posted in Q3 FY26. However, the year-on-year comparison reveals a concerning 16.42% decline from ₹23.32 crores in Q4 FY25, highlighting the volatility that has characterised the company's recent performance.

2 hours ago
Share Via
Foods & Inns Q4 FY26: Strong Quarter Masks Underlying Weakness

Mini Diamonds (India) Q4 FY26: Sharp Loss Overshadows Revenue Growth as Margins Collapse

Mini Diamonds (India) Ltd., a Mumbai-based diamond trading and manufacturing company, reported a stark reversal in its fourth-quarter performance for FY26, posting a net loss of ₹6.18 crores compared to a profit of ₹2.84 crores in the previous quarter. Despite revenue growth of 54.89% year-on-year to ₹149.98 crores, the company's operating margins collapsed into deeply negative territory at -5.47%, raising serious concerns about operational efficiency and cost management in what should have been a strong revenue quarter.

2 hours ago
Share Via
Mini Diamonds (India) Q4 FY26: Sharp Loss Overshadows Revenue Growth as Margins Collapse

Hilton Metal Forging Q4 FY26: Profit Plummets 97% as Operating Margins Compress Sharply

Hilton Metal Forging Ltd., a micro-cap castings and forgings company with a market capitalisation of ₹113.00 crores, reported deeply concerning results for Q4 FY26, with net profit collapsing 97% quarter-on-quarter to just ₹0.14 crores from ₹1.42 crores in Q3 FY26. The stock, currently trading at ₹22.25, has declined 65.67% over the past year, significantly underperforming its sector peers and reflecting mounting investor concerns about the company's operational trajectory.

2 hours ago
Share Via
Hilton Metal Forging Q4 FY26: Profit Plummets 97% as Operating Margins Compress Sharply

Explicit Finance Q4 FY26: Losses Deepen as Revenue Collapses 72% YoY

Explicit Finance Ltd., a micro-cap non-banking financial company, reported a concerning fourth quarter for FY26, with the company slipping into losses of ₹0.15 crores compared to a loss of ₹0.03 crores in the same quarter last year. The quarter was marked by a dramatic 71.61% year-on-year revenue decline and negative operating margins, raising serious questions about the sustainability of the company's business model.

2 hours ago
Share Via
Explicit Finance Q4 FY26: Losses Deepen as Revenue Collapses 72% YoY

Fischer Medical Ventures Q4 FY26: Profitability Collapses Despite Revenue Surge

Fischer Medical Ventures Ltd., a small-cap commodity chemicals player transitioning into medical imaging technology trading, reported a jarring reversal in Q4 FY26, posting a consolidated net loss of ₹7.10 crores compared to a profit of ₹19.23 crores in the previous quarter—a staggering 136.92% quarter-on-quarter decline. Despite net sales of ₹97.73 crores representing a robust 98.76% year-on-year growth, the company's profitability collapsed under the weight of surging interest costs and margin compression. The stock, trading at ₹38.11 on May 29, 2026, has tumbled 56.45% over the past year, significantly underperforming both the Sensex and its commodity chemicals sector peers.

2 hours ago
Share Via
Fischer Medical Ventures Q4 FY26: Profitability Collapses Despite Revenue Surge

Kings Infra Ventures Q4 FY26: Strong Profit Surge Masks Underlying Concerns

Kings Infra Ventures Ltd., a micro-cap infrastructure and aquaculture company with a market capitalisation of ₹292.00 crores, reported a robust 90.44% year-on-year surge in consolidated net profit to ₹5.18 crores for the quarter ended March 2026 (Q4 FY26). However, the impressive headline numbers conceal deeper concerns about operational sustainability, with the stock trading 31.85% below its 52-week high and technical indicators flashing warning signals despite the strong quarterly performance.

2 hours ago
Share Via
Kings Infra Ventures Q4 FY26: Strong Profit Surge Masks Underlying Concerns

Sanblue Corporation Q4 FY26: Deepening Losses Signal Structural Distress

Sanblue Corporation Ltd., a micro-cap garments and apparels company, reported a concerning fourth-quarter performance for FY26, posting a net loss of ₹0.07 crores compared to a loss of ₹0.02 crores in the corresponding quarter last year. The stock has plunged 45.02% over the past year, significantly underperforming the Sensex's 8.40% decline, as investors flee the deteriorating fundamentals and persistent operational challenges. With a market capitalisation of just ₹18.00 crores, the company's inability to generate consistent profits despite sporadic revenue has raised serious questions about its viability.

2 hours ago
Share Via
Sanblue Corporation Q4 FY26: Deepening Losses Signal Structural Distress

Alpa Laboratories Q4 FY26: Profit Recovery Masks Deeper Revenue Concerns

Alpa Laboratories Ltd., a micro-cap pharmaceutical manufacturer with a market capitalisation of ₹148.00 crores, reported a net profit of ₹1.38 crores for Q4 FY26, marking a sharp recovery from the previous year's loss of ₹2.12 crores. However, the positive earnings reversal conceals troubling revenue trends, as net sales declined 21.34% year-on-year to ₹31.40 crores, raising questions about the sustainability of the company's business momentum in an otherwise buoyant pharmaceutical sector.

2 hours ago
Share Via
Alpa Laboratories Q4 FY26: Profit Recovery Masks Deeper Revenue Concerns

Sulabh Engineers Q4 FY26: Sharp Quarterly Loss Raises Serious Concerns Despite Full-Year Turnaround

Sulabh Engineers & Services Ltd., a Mumbai-based non-banking financial company, reported a consolidated net loss of ₹0.96 crores for Q4 FY26 (March 2026 quarter), marking a dramatic reversal from the ₹1.14 crores profit recorded in Q3 FY26 and a steep 328.57% year-on-year decline from the ₹0.42 crores profit in Q4 FY25. The micro-cap NBFC, with a market capitalisation of ₹32.00 crores, saw its stock price edge up 1.97% to ₹3.10 on May 29, 2026, despite the concerning quarterly results.

2 hours ago
Share Via
Sulabh Engineers Q4 FY26: Sharp Quarterly Loss Raises Serious Concerns Despite Full-Year Turnaround

Abate As Industries Q4 FY26: Profit Surge Masks Valuation Concerns

Abate As Industries Ltd., a micro-cap hospital operator with a market capitalisation of ₹158.00 crores, reported a consolidated net profit of ₹2.93 crores for Q4 FY26, marking a remarkable 146.22% year-on-year surge from ₹1.19 crores in Q4 FY25. However, the quarter-on-quarter performance revealed a 4.25% decline from ₹3.06 crores in Q3 FY26, signalling potential momentum challenges. The stock, trading at ₹10.39 as of May 29, 2026, has delivered a modest 2.87% gain in the latest trading session but remains deeply underwater on a year-to-date basis, down 40.63%.

2 hours ago
Share Via
Abate As Industries Q4 FY26: Profit Surge Masks Valuation Concerns

Deep Health AI India Q4 FY26: Severe Loss Triggers 78% Crash from Peak

Deep Health AI India Ltd., a micro-cap company operating in the gems and jewellery sector with recent forays into pharmaceutical consultancy, reported a devastating fourth quarter for FY26, posting a consolidated net loss of ₹4.51 crores compared to a profit of ₹0.35 crores in the same quarter last year. The catastrophic 1,388.57% year-on-year decline in profitability sent the stock tumbling to ₹2.21, down 78.52% from its 52-week high of ₹10.29, with the company's market capitalisation shrinking to just ₹34.00 crores.

2 hours ago
Share Via
Deep Health AI India Q4 FY26: Severe Loss Triggers 78% Crash from Peak

GVK Power & Infrastructure Q4 FY26: Revenue Collapse Signals Deepening Distress

GVK Power & Infrastructure Ltd., a diversified infrastructure holding company with interests in power generation, roads, and airports, reported a complete revenue collapse in Q4 FY26, posting zero sales for the quarter compared to ₹80.53 crores in the previous quarter. The company recorded a consolidated net loss of ₹3.00 crores, marking the continuation of a troubling operational shutdown that began in Q3 FY26. With a market capitalisation of just ₹485.00 crores and the stock trading at ₹3.04, investors are witnessing the unravelling of what was once a significant infrastructure conglomerate.

2 hours ago
Share Via
GVK Power & Infrastructure Q4 FY26: Revenue Collapse Signals Deepening Distress

SBEC Sugar Q4 FY26: Exceptional Profit Surge Masks Underlying Structural Weaknesses

SBEC Sugar Ltd. delivered a stunning turnaround in Q4 FY26 with consolidated net profit surging to ₹90.59 crores, marking a remarkable 95.45% year-on-year increase from ₹46.35 crores in Q4 FY25. However, this extraordinary quarterly performance stands in stark contrast to the company's dismal full-year results and deteriorating financial health, raising serious questions about sustainability and underlying business quality.

2 hours ago
Share Via
SBEC Sugar Q4 FY26: Exceptional Profit Surge Masks Underlying Structural Weaknesses

Semac Construction Q4 FY26: Strong Quarter Masks Deeper Structural Concerns

Semac Consultants Ltd. (formerly Revathi Equipment Ltd.) reported a consolidated net profit of ₹4.73 crores for Q4 FY26, marking an impressive 237.86% quarter-on-quarter surge and a 392.71% year-on-year leap. However, this seemingly stellar performance conceals troubling structural weaknesses that continue to plague the ₹100 crore micro-cap construction company. Despite the quarterly profit spike, the stock has declined 0.10% following the results announcement, reflecting investor scepticism about sustainability.

2 hours ago
Share Via
Semac Construction Q4 FY26: Strong Quarter Masks Deeper Structural Concerns